Anti-colorectal cancer effects of a novel camptothecin derivative pcc0208037 in vitro and in vivo

HIGHLIGHTS

• who: Min Li et al. from the School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Drugs in Universities of Shandong, Yantai University, Yantai, China have published the Article: Anti-Colorectal Cancer Effects of a Novel Camptothecin Derivative PCC0208037 In Vitro and In Vivo, in the Journal: Pharmaceuticals 2023, 53 of /2023/
• what: The authors report for the first time that PCC0208037, a novel orectal cancer, with mixed results .
• how: The MTT results showed that PCC0208037 HCT116 HT-29 and CT-26). The tissue distribution results showed that the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.